Yui Hasebe

is actively pursuing at least three acquisition opportunities and considering expanding US manufacturing capacity, as the Japanese drugmaker seeks to diversify its production base and geopolitical risk over the next decade. The Osaka-based company is looking for acquisition targets in the US, Japan and Europe that specialize in infectious and rare diseases, Chairman and Chief Executive Officer said in a Bloomberg TV interview. Shionogi is “actively pursuing” a minimum of three deals, he said.

Source: Trusco Nakayama Corp. (Bloomberg) -- The glass door closes, and a curtain of cool air spills over your head, neck and shoulders, delivering instant relief from the punishing summer heat. This is what it’s like to chill in the Do Hiemon Box, an oversized stainless-steel refrigerator that looks big enough to fit a human being, because that’s exactly what it’s designed to do. Trusco Nakayama Corp.